Dr. Gabriela Orgeron, M.D.
What this data tells you about Dr. Orgeron
Dr. Gabriela Orgeron is an internal medicine specialist in Sugar Land, TX, with 13 years of NPI registration. Based on federal Medicare data, Dr. Orgeron performed 2,668 Medicare services across 1,914 unique beneficiaries.
Between the years covered by Open Payments, Dr. Orgeron received a total of $3,730 from 27 pharmaceutical and/or device companies across 209 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Orgeron is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test | 504 | $48 | $152 |
| EKG interpretation and report | 459 | $6 | $23 |
| Office visit, established patient (30-39 min) | 433 | $82 | $287 |
| Echocardiogram, transthoracic | 157 | $134 | $592 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 136 | $97 | $1,715 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 131 | $333 | $1,273 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 130 | $48 | $203 |
| Heart muscle strain imaging | 118 | $28 | $107 |
| Prothrombin time test (blood clotting) | 103 | $4 | $15 |
| Anticoagulant management of patient taking warfarin | 86 | $7 | $34 |
| Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 66 | $9 | $12 |
| Hospital follow-up visit, moderate complexity | 58 | $61 | $196 |
| Electrocardiogram (EKG), 12-lead | 39 | $10 | $45 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 33 | $10 | $40 |
| New patient office visit (45-59 min) | 30 | $120 | $439 |
| Initial hospital admission, moderate complexity | 27 | $99 | $371 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 26 | $20 | $73 |
| Heart rhythm recording of continous external ekg over 8-15 days | 23 | $9 | $40 |
| Programming of dual lead pacemaker system | 18 | $48 | $156 |
| Ultrasound of heart, follow-up | 16 | $67 | $327 |
| Initial hospital admission, high complexity | 15 | $136 | $549 |
| Office visit, established patient (20-29 min) | 13 | $51 | $195 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 12 | $14 | $73 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 12 | $18 | $67 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 12 | $13 | $72 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 11 | $9 | $40 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Orgeron is a cardiac imaging specialist, with above-average Medicare volume (top 13% in TX), with low-engagement industry engagement in the top 20% of TX peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Orgeron experienced with regadenoson injection (lexiscan) for heart stress test?
Does Dr. Orgeron receive payments from pharmaceutical companies?
How do Dr. Orgeron's costs compare to other internal medicine physicians in Sugar Land?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology